Published date: 21 August 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Antineoplastic and immunomodulating agents - 33652000
Location of contract
E14 4PU
Value of contract
£240,000
Procurement reference
CF-2551900D0O000000rwimUAA
Published date
21 August 2024
Closing date
14 June 2024
Closing time
12pm
Contract start date
19 August 2024
Contract end date
14 July 2027
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
UK Health Security Agency (UKHSA) has awarded a contract to The Native Antigen Company (LGC Group) for the provision of viral antigens.
More information
Attachments
-
- REDACTED FINAL Viral Antigens-C234400_Short_Form_Contract.pdf
- REDACTED FINAL Viral Antigens-C234400_Short_Form_Contract
Award information
Awarded date
19 August 2024
Contract start date
19 August 2024
Contract end date
14 July 2027
Total value of contract
£240,000
This contract was awarded to 1 supplier.
The Native Antigen Company (LGC Group)
Address
Unit 3 Oxford Technology Park OX5 1GN
Reference
None
About the buyer
Contact name
Commercial Operations
Address
10 South Colonnade
London
E14 4PU
United Kingdom
Share this notice
Closing: 14 June 2024, 12pm
All content is available under the
